Financials
Income statement
| Fiscal date | Jan 2025 | Oct 2024 | Jul 2024 | Apr 2024 |
|---|---|---|---|---|
| Total reported revenue | 14.9B | 14.1B | 13.1B | 12.5B |
| Cost of revenue | 4.8B | 5.1B | 4.7B | 4.7B |
| Gross profit | 10.1B | 9.0B | 8.4B | 7.8B |
| Operating expense | ||||
| Research & development | 2.3B | 2.2B | 2.4B | 2.4B |
| Selling general and admin | 949M | 1.0B | 1.1B | 1.3B |
| Other operating expenses | — | — | — | — |
| Operating income | 6.4B | 4.9B | 4.1B | 3.3B |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | 873M | 916M | 1.1B | 1.0B |
| Other income expense | -69M | -727M | -221M | -205M |
| Pretax income | 5.5B | 3.8B | 2.8B | 2.0B |
| Tax provision | -13M | -442M | 4.2B | -116M |
| Net income | 5.5B | 4.3B | -1.9B | 2.1B |
| Basic EPS | 0.2 | 0.2 | -0.1 | 0.1 |
| Diluted EPS | 0.2 | 0.2 | -0.1 | 0.1 |
| Basic average shares | 19.1B | 19.0B | 19.0B | 18.9B |
| Diluted average shares | 19.7B | 19.6B | 19.0B | 19.5B |
| EBITDA | 8.7B | 7.6B | 6.7B | 5.9B |
| Net income from continuing op. | 5.5B | 4.3B | -1.9B | 2.1B |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |